# PLx Pharma Inc.: Form D filings

PLx Pharma Inc., a pharmaceuticals company in Sparta, NJ, filed 9 Form D notices with the SEC between 2010 and 2020. The latest, on November 30, 2020, reports $18 million sold of a $18 million offering to 25 investors.

Find out what PLx Pharma Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20PLx%20Pharma%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=PLx%20Pharma%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fplx-pharma-inc-1497504)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20PLx%20Pharma%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=PLx%20Pharma%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fplx-pharma-inc-1497504)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in New Jersey](https://specstream.ai/data/form-d/state/new-jersey): 714 rows, by operating companies, filed since November 1, 2024, $35.70, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/new-jersey
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 9 FISHERS LANE, SUITE E, Sparta, NJ, 07871
- Phone: (973) 409-6541
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1497504

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Nov 30, 2020 | New notice | $18,008,599 | $18,008,599 | $0 | 25 | Nov 18, 2020 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1497504/000092189520003128/0000921895-20-003128-index.htm) |
| May 29, 2020 | New notice | $8,000,000 | $8,000,000 | $0 | 3 | May 15, 2020 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1497504/000092189520001635/0000921895-20-001635-index.htm) |
| Mar 4, 2019 | New notice | $15,000,000 | $15,000,000 | $0 | 2 | Feb 20, 2019 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1497504/000092189519000636/0000921895-19-000636-index.htm) |
| Jun 28, 2017 | New notice | $18,191,869 | $18,191,869 | $0 | 37 | Jun 14, 2017 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1497504/000129152017000002/0001291520-17-000002-index.htm) |
| Jul 22, 2013 | New notice | $5,500,000 | $2,750,000 | $2,750,000 | 28 | Jul 12, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1497504/000146581813000006/0001465818-13-000006-index.htm) |
| Feb 25, 2013 | New notice | $1,750,000 | $930,000 | $820,000 | 8 | Feb 13, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1497504/000146581813000001/0001465818-13-000001-index.htm) |
| Apr 23, 2012 | New notice | $2,500,000 | $507,500 | $1,992,500 | 16 | Mar 30, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1497504/000146581812000005/0001465818-12-000005-index.htm) |
| Nov 7, 2011 | Amendment | $3,000,000 | $2,740,000 | $260,000 | 34 | Jul 23, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1497504/000146581811000016/0001465818-11-000016-index.htm) |
| Jul 30, 2010 | New notice | $2,500,000 | $1,070,000 | $1,430,000 | 23 | Jul 23, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1497504/000146581810000024/0001465818-10-000024-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Natasha Giordano | Executive Officer, Director |  |
| Rita O'Connor | Executive Officer |  |
| John W. Hadden II | Director |  |
| Anthony J. Bartsh | Director |  |
| Kirk J. Calhoun | Director |  |
| Robert J. Casale | Director |  |
| Gary J. Balkema | Director |  |
| Michael J. Valentino | Executive Officer, Director |  |

## Other pharmaceuticals companies in New Jersey that filed recently

- [Grace Therapeutics, Inc.](https://specstream.ai/data/form-d/company/grace-therapeutics-inc-1444192) $10 million · Aug 11, 2026

[Every Form D from the week of Nov 30, 2020](https://specstream.ai/data/form-d/week/2020-11-30) · [All recent filings in New Jersey](https://specstream.ai/data/form-d/state/new-jersey) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what PLx Pharma Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).